Total Debt for Alnylam Pharmaceuticals (ALNY)
According to Alnylam Pharmaceuticals's latest reported financial statements, the company's latest reported total debt is $1.28B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$1.28B
YoY change
-53.4%
5Y CAGR
+19.7%
Peak year (2024)
$2.74B
Latest annual
$1.28B
Total Debt history chart for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025
Total Debt history table for Alnylam Pharmaceuticals (ALNY) from 2002 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $1.28B | -53.4% | ||
| 2024 | $2.74B | +110.2% | ||
| 2023 | $1.31B | -1.1% | ||
| 2022 | $1.32B | +32.3% | ||
| 2021 | $997.59M | +91.4% | ||
| 2020 | $521.19M | +71.5% | ||
| 2019 | $303.82M | +912.7% | ||
| 2018 | $30.00M | 0.0% | ||
| 2017 | $30.00M | -80.0% | ||
| 2016 | $150.00M | — | ||
| 2015 | $0 | — | ||
| 2014 | $0 | — | ||
| 2013 | $0 | — | ||
| 2012 | $0 | — | ||
| 2011 | $0 | — | ||
| 2010 | $0 | — | ||
| 2009 | $0 | — | ||
| 2008 | $0 | -100.0% | ||
| 2007 | $6.76M | -26.0% | ||
| 2006 | $9.14M | +23.5% | ||
| 2005 | $7.39M | +2.7% | ||
| 2004 | $7.20M | +287.4% | ||
| 2003 | $1.86M | — | ||
| 2002 | $0 | — |
Total Debt values are taken from Alnylam Pharmaceuticals's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Alnylam Pharmaceuticals (ALNY) total debt is $1.28B – plunged 53.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Alnylam Pharmaceuticals total debt compounded at +19.7% per year, with the latest reading among the more recent periods of the dataset.
The dataset's maximum total debt sits at $2.74B (2024); the minimum reading of $0 dates to 2002.
Within Healthcare, Alnylam Pharmaceuticals (ALNY) ranks 9th among 8 peers we track. The peer median for total debt is $52.57B.
Alnylam Pharmaceuticals Total Debt by Year
Alnylam Pharmaceuticals Total Debt 2025: $1.28B
Alnylam Pharmaceuticals total debt in 2025 was $1.28B, plunged 53.4% below 2024.
Alnylam Pharmaceuticals Total Debt 2024: $2.74B
Alnylam Pharmaceuticals total debt in 2024 was $2.74B, surged 110.2% from 2023. This figure represents the highest annual value in the available history.
Alnylam Pharmaceuticals Total Debt 2023: $1.31B
Alnylam Pharmaceuticals total debt in 2023 was $1.31B, edged down 1.1% below 2022.
Alnylam Pharmaceuticals Total Debt 2022: $1.32B
Alnylam Pharmaceuticals total debt in 2022 was $1.32B, surged 32.3% from 2021.
Alnylam Pharmaceuticals Total Debt 2021: $997.59M
Alnylam Pharmaceuticals total debt in 2021 was $997.59M.
See more financial history for Alnylam Pharmaceuticals (ALNY).
Sector peers — Total Debt
Companies in the same sector as Alnylam Pharmaceuticals, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Alnylam Pharmaceuticals's total debt?
- Latest reported total debt for Alnylam Pharmaceuticals (ALNY) is $1.28B (period ending December 31, 2025).
How has Alnylam Pharmaceuticals total debt changed year-over-year?
- Alnylam Pharmaceuticals (ALNY) total debt changed -53.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Alnylam Pharmaceuticals total debt?
- Alnylam Pharmaceuticals (ALNY) total debt compound annual growth rate is +19.7% over the most recent 5 years available.
When did Alnylam Pharmaceuticals total debt hit its highest annual value?
- Alnylam Pharmaceuticals total debt reached its highest annual value of $2.74B in 2024.
What was Alnylam Pharmaceuticals total debt in 2024?
- Alnylam Pharmaceuticals (ALNY) total debt in 2024 was $2.74B.
What was Alnylam Pharmaceuticals total debt in 2025?
- Alnylam Pharmaceuticals (ALNY) total debt in 2025 was $1.28B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ALNY Overview
Company profile, financial tools, and key metrics
ALNY Revenue Counter
Earns $117.77 every second. See per minute, hour, and day.
ALNY Earnings Counter
Earns $9.95 per second net profit. See per minute, hour, and day.
ALNY Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
ALNY What If Invested
What if you had invested $1,000? See historical returns from any date.
ALNY How It Makes Money
Discover visual breakdown of $3.71B in revenue — where it comes from and where it goes.
ALNY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ALNY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ALNY Daily Price Character
Explosive · 50.6% historical win rate (green days). Streaks & record days.
ALNY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.